½ÃÀ庸°í¼­
»óǰÄÚµå
1372898

ÇコÄɾî¿ë EConsent ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø(2018-2028³â) : Ç÷§Æûº°, µî·Ï À¯Çüº°, ¾ç½Ä À¯Çüº°, Áö¿ªº°, °æÀï

EConsent In Healthcare Market, 2028- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Platform, By Enrollment Type, By Form Type, By Region, By Competition.

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÇコÄɾî¿ë EConsent ¼¼°è ½ÃÀåÀº 2022³â 3¾ï 103¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2028³â±îÁö ¿¬Æò±Õ 11.73% ¼ºÀåÇØ ¿¹Ãø ±â°£ µ¿¾È °­·ÂÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖ±Ù ¸î ³â µ¿¾È ÀÇ·á¾÷°è´Â ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ °ü°è¿¡¼­ Å« º¯È­¸¦ °Þ¾ú½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¹ßÀü Áß Çϳª´Â ÀüÀÚµ¿ÀÇ(EConsent)ÀÇ º¸±ÞÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº °ü¸® ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇßÀ» »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ°¡ ÀÇ·á °ü·Ã ÀÇ»ç°áÁ¤¿¡ º¸´Ù Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

±âÁ¸¿¡´Â ÀÇ·á ½Ã¼úÀ̳ª ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ È¯ÀÚÀÇ »çÀü µ¿ÀǸ¦ ¾ò±â À§ÇØ ¹æ´ëÇÑ ¾çÀÇ ¼­·ù°¡ ÇÊ¿äÇϰí, ¶§·Î´Â È¥¶õ½º·¯¿î ¹ý·ü ¿ë¾î°¡ Æ÷ÇԵŠÀÖ½À´Ï´Ù. ȯÀÚµéÀº Á¾Á¾ ¾Ðµµ´çÇϰí ÀÚ½ÅÀÇ °áÁ¤ÀÇ Àǹ̸¦ ÁøÁ¤À¸·Î ÀÌÇØÇϱ⠾î·Á¿ü´Âµ¥, EConsent´Â ÅÂºí¸´, ½º¸¶Æ®Æù, À¥ ¾ÖÇø®ÄÉÀ̼ǰú °°Àº ÀüÀÚ Ç÷§ÆûÀ» »ç¿ëÇÏ¿© ȯÀÚ¿¡°Ô µ¿ÀÇ Á¤º¸¸¦ ¸íÈ®Çϰí ÀÎÅÍ·¢Æ¼ºêÇÑ ¹æ½ÄÀ¸·Î Á¦½ÃÇÕ´Ï´Ù. ȯÀÚ´Â ¼¼ºÎ »çÇ×À» È®ÀÎÇϰí, Áú¹®Çϰí, µ¿ÀǼ­¿¡ ÀüÀÚÀûÀ¸·Î ¼­¸íÇÒ ¼ö ÀÖÀ¸¸ç, µ¿½Ã¿¡ ÀÌÇØ¸¦ µ½±â À§ÇÑ ±³À° ÀÚ·á¿Í ¸ÖƼ¹Ìµð¾î ¸®¼Ò½º¿¡ Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ Á᫐ ÀÇ·á·ÎÀÇ ÀüȯÀº Áß¿äÇÑ ¿øµ¿·ÂÀÔ´Ï´Ù. ȯÀÚµéÀº ÀÇ·á °áÁ¤¿¡ ÀÖ¾î Àû±ØÀûÀÎ ¿ªÇÒÀ» ¼öÇàÇϸç Åõ¸í¼º°ú ÆíÀǼºÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. À¯·´ÀÇ GDPR, ¹Ì±¹ÀÇ HIPAA¿Í °°Àº ÀÇ·á ºÐ¾ßÀÇ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ¾ÈÀüÇÏ°í ±ÔÁ¤À» ÁؼöÇÏ´Â EConsent ¼Ö·ç¼ÇÀ» äÅÃÇϵµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ®Æù°ú ÅÂºí¸´ÀÇ º¸±Þ°ú ÀÎÅÍ³Ý ¿¬°áÀÇ Çâ»óÀ¸·Î ÀÇ·á ±â°üÀº EConsent ¼Ö·ç¼ÇÀ» ½±°Ô µµÀÔÇÒ ¼ö ÀÖ°Ô µÇ¾úÀ¸¸ç, EConsent´Â °ü¸® ºÎ´ãÀ» ÁÙÀ̰í, ¼­·ù ÀÛ¾÷À» ÁÙÀ̸ç, µ¿ÀÇ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ¿© ±Ã±ØÀûÀ¸·Î ÀÇ·á±â°üÀÇ ½Ã°£°ú ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. COVID-19 »çÅ·ΠÀÎÇØ ¿ø°Ý ºÐ»êÇü ÀÓ»ó½ÃÇèÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ´Â °¡¿îµ¥, EConsent´Â Âü¿©ÀÚÀÇ »çÀü µ¿ÀǸ¦ ¾ò´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ßÀÇ ¼¼°è EConsent ½ÃÀåÀº ȯÀÚ°¡ ÀÇ·á ÀÇ»ç°áÁ¤¿¡ Âü¿©ÇÏ´Â ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. EConsent´Â º¸´Ù Åõ¸íÇϰí È¿À²ÀûÀ̸ç ȯÀÚ Áß½ÉÀÇ »çÀü µ¿ÀÇ Á¢±Ù ¹æ½ÄÀ» ÃËÁøÇÔÀ¸·Î½á ȯÀÚ»Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á Á¦°øÀÚ ¹× ¿¬±¸ÀÚ¿¡°Ôµµ ÇýÅÃÀ» Á¦°øÇÕ´Ï´Ù. ±â¼úÀÌ °è¼Ó ¹ßÀüÇϰí ÀÇ·á »ê¾÷ÀÌ ÁøÈ­Çϴ ȯÀÚÀÇ ¿ä±¸¿¡ ÀûÀÀÇÔ¿¡ µû¶ó EConsent´Â Çö´ë ÀÇ·á ÇàÀ§¿¡¼­ Á¡Á¡ ´õ Áß½ÉÀûÀÎ ¿ªÇÒÀ» ÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2024-2028³â
2022³â ½ÃÀå ±Ô¸ð 3¾ï 103¸¸ ´Þ·¯
2028³â ½ÃÀå ±Ô¸ð 5¾ï 8,322¸¸ ´Þ·¯
CAGR 2023-2028³â 11.73%
±Þ¼ºÀå ºÎ¹® ÀÏ¹Ý µ¿ÀÇ
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

ȯÀÚ Âü¿© °­È­°¡ ÇコÄɾî¿ë EConsent ¼¼°è ½ÃÀåÀ» ÁÖµµ

ÃÖ±Ù ¸î ³â µ¿¾È ÀÇ·á´Â ±â¼úÀÇ ¹ßÀü°ú ȯÀÚµéÀÇ ±â´ëÄ¡ º¯È­¿¡ ÈûÀÔ¾î Å« º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â ÀüÀÚµ¿ÀÇ(EConsent) ¼Ö·ç¼ÇÀÇ µµÀÔÀ¸·Î, ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ¼ÒÅëÇÏ´Â ¹æ½Ä¿¡ Çõ¸íÀ» ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ȯÀÚ Âü¿©ÀÇ °­È­´Â »çÀü µ¿ÀÇ ÇÁ·Î¼¼½º¸¦ À籸¼ºÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÔÀ¸·Î½á ¼¼°è EConsent ½ÃÀåÀ» ÁÖµµÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. EConsent Ç÷§ÆûÀº ºñµð¿À, ¾Ö´Ï¸ÞÀ̼Ç, °£°áÇÑ ¾ð¾î¿Í °°Àº ¸ÖƼ¹Ìµð¾î ¿ä¼Ò¸¦ Ȱ¿ëÇÏ¿© ȯÀÚ¿¡°Ô ÀÇ·á Á¤º¸¸¦ Á¦°øÇÏ´Â µî ÀÇ·áÀÇ µðÁöÅÐ Çõ½Å¿¡ ÈûÀÔ¾î ȯÀÚ Âü¿©°¡ °­È­µÇ¸é¼­ »óȲÀÌ ¹Ù²î°í ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ȯÀÚµéÀº Ä¡·á ¿É¼Ç, À§Çè, ÇýÅÿ¡ ´ëÇÑ ÀÌÇØ¸¦ µ½°í, Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ°Ô µË´Ï´Ù. ȯÀÚ´Â EConsent Ç÷§ÆûÀ» ÅëÇØ ÀÇ·áÁø°ú ¼ÒÅëÇÒ ¼ö ÀÖÀ¸¸ç, ÀÚ½ÅÀÇ ÆíÀÇ¿¡ µû¶ó Áú¹®À» Çϰųª ¼³¸íÀ» ¿äûÇÒ ¼ö ÀÖ½À´Ï´Ù. EConsent ¼Ö·ç¼ÇÀº Á¾Á¾ ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°ú ÅëÇյǾî ȯÀÚ°¡ ÀÚ½ÅÀÇ º´·Â, °Ë»ç °á°ú, Ä¡·á °èȹ¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Çϸç, ÀÌ·¯ÇÑ Åõ¸í¼ºÀ» ÅëÇØ ȯÀÚµéÀº ÀÚ½ÅÀÇ Ä¡·á¿¡ ´ëÇÑ Âü¿©°¨À» ³ôÀÌ°í ºÒ¾ÈÀ» ÁÙÀÌ¸ç ½Å·Ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Åõ¸í¼ºÀ» ÅëÇØ ȯÀÚ´Â ÀÚ½ÅÀÇ Ä¡·á¿¡ ´ëÇÑ ³íÀÇ¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̴ ƯÈ÷ ¿ø°Ý ÀÇ·á ½Ã´ë¿¡ Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ À¯¿¬¼ºÀ» ÅëÇØ ¹°¸®ÀûÀ¸·Î ÀÇ·á±â°üÀ» ¹æ¹®ÇÒ ¼ö ¾ø´Â ȯÀڵ鵵 Ä¡·á °áÁ¤¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÇÕ¸®È­µÈ ¿öÅ©Ç÷οìÀÇ Áõ°¡·Î ¼¼°è ½ÃÀå °ßÀÎ

¼¼°è ÀüÀÚµ¿ÀÇ(EConsent) ½ÃÀåÀº ÁÖ·Î ÀÇ·á ȯ°æ¿¡¼­ °£¼ÒÈ­µÈ ¿öÅ©Ç÷οìÀÇ Çʿ伺À¸·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. »çÀü µ¿ÀÇ´Â ÀÇ·á ÇàÀ§ÀÇ ±âº» ¿ä¼Ò·Î, ȯÀÚ°¡ ÀÇ·á ÀýÂ÷ ¹× Ä¡·áÀÇ À§Çè°ú ÇýÅÃÀ» ÀÌÇØÇÏ°í µ¿ÀÇÇÏ´Â °ÍÀ» º¸ÀåÇÕ´Ï´Ù. ±âÁ¸¿¡´Â ÀÌ °úÁ¤¿¡ Á¾ÀÌ ¾ç½ÄÀÌ ÇÊ¿äÇϰí ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ ±ä ´ëÈ­°¡ ÇÊ¿äÇß½À´Ï´Ù. ÇÏÁö¸¸ ÃÖ±Ù ÀÇ·á°è´Â ÀüÀÚ µ¿ÀÇ ¼Ö·ç¼ÇÀ¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)°ú À¯·´ÀǾàǰû(EMA)°ú °°Àº ±ÔÁ¦ ±â°üÀº ÀüÀÚ µ¿ÀÇÀÇ ÀÌÁ¡À» ÀνÄÇϰí ÀÖÀ¸¸ç, ȯÀÚÀÇ ÀÌÇØ¿Í ÁؼöÀÇ Á߿伺À» °­Á¶Çϸ鼭 ÀüÀÚ µ¿ÀÇ ÇÁ·Î¼¼½ºÀÇ Ã¤ÅÃÀ» Àå·ÁÇÏ´Â °¡À̵å¶óÀΰú ±ÔÁ¤À» Á¦Á¤Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦¿¡ ÈûÀÔ¾î ÀÇ·á ±â°üµéÀº ÀÌ·¯ÇÑ ±âÁØÀ» ÃæÁ·ÇÏ´Â EConsent ¼Ö·ç¼ÇÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ Áß½ÉÀÇ Ä¡·á´Â ÀÇ·á Çõ½ÅÀÇ ¿øµ¿·ÂÀ̸ç, EConsent´Â ÀÌ ¿øÄ¢¿¡ ¿Ïº®ÇÏ°Ô ºÎÇÕÇÕ´Ï´Ù. ȯÀÚµéÀº Æí¾ÈÇÑ ±â±â¿¡¼­ µ¿ÀǼ­¿¡ µðÁöÅÐ ¼­¸íÀ» ÇÒ ¼ö ÀÖ´Â Æí¸®ÇÔÀ» ³ôÀÌ Æò°¡Çϸç, Á¾ÀÌ ¾ç½ÄÀÇ ¹ø°Å·Î¿òÀ» ÇÇÇÏ°í ´ë±â ½Ã°£À» ´ÜÃàÇÕ´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ °æÇèÀÇ °³¼±Àº ȯÀÚ ¸¸Á·µµ¿Í Âü¿©µµ Çâ»óÀ¸·Î À̾îÁý´Ï´Ù.

ÁÖ¿ä ½ÃÀå °úÁ¦

±ÔÁ¦»óÀÇ °úÁ¦

ÇコÄɾî¿ë EConsent ¼¼°è ½ÃÀå¿¡¼­ÀÇ °¡Àå Å« µµÀü °úÁ¦ Áß Çϳª´Â ³¯·Î ÁøÈ­ÇÏ´Â ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÇ·á ºÐ¾ß´Â ±ÔÁ¦°¡ ¸Å¿ì ¾ö°ÝÇϸç, EConsent ¼Ö·ç¼ÇÀº ȯÀÚ ÇÁ¶óÀ̹ö½Ã, µ¥ÀÌÅÍ º¸¾È ¹× µ¿ÀÇ ¹®¼­¿Í °ü·ÃµÈ ¼ö¸¹Àº Áö¿ª ¹× ±¹°¡ ¹ý·üÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ºñ¿ëÀÌ ¸¹ÀÌ µé ¼ö ÀÖ½À´Ï´Ù. À¯·´¿¬ÇÕÀÇ ÀÏ¹Ý µ¥ÀÌÅÍ º¸È£ ±ÔÁ¤(GDPR)À̳ª ¹Ì±¹ÀÇ ÀǷẸÇè »óÈ£¿î¿ë¼º ¹× Ã¥ÀÓ¿¡ °üÇÑ ¹ý·ü(HIPAA)°ú °°Àº »õ·Î¿î ±ÔÁ¤ÀÇ µµÀÔÀº º¹À⼺À» ´õ¿í °¡Áß½Ã۰í ÀÖÀ¸¸ç, EConsent Á¦°ø¾÷ü´Â ±ÔÁ¤À» ÁؼöÇϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î ½Ã½ºÅÛÀ» ¾÷µ¥ÀÌÆ®ÇØ¾ß ÇÕ´Ï´Ù. Áö¼ÓÀûÀ¸·Î ½Ã½ºÅÛÀ» ¾÷µ¥ÀÌÆ®ÇØ¾ß Çϴµ¥, ÀÌ´Â ¾î·Æ°í ¸¹Àº ¸®¼Ò½º°¡ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù.

µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎÁ¤º¸ º¸È£

EConsent Ç÷§ÆûÀº ¹Î°¨ÇÑ È¯ÀÚ Á¤º¸¸¦ ´Ù·ç±â ¶§¹®¿¡ µ¥ÀÌÅÍ º¸¾È°ú ÇÁ¶óÀ̹ö½Ã°¡ °¡Àå Å« °ü½É»çÀÔ´Ï´Ù. ȯÀÚ µ¥ÀÌÅ͸¦ Ä§ÇØ ¹× ¹«´Ü ¾×¼¼½º·ÎºÎÅÍ ¾ÈÀüÇÏ°Ô º¸È£ÇÏ´Â °ÍÀº ¸Å¿ì Áß¿äÇÕ´Ï´Ù. »çÀ̹ö À§ÇùÀÌ °è¼Ó ÁøÈ­ÇÔ¿¡ µû¶ó, EConsent Á¦°ø¾÷ü´Â °­·ÂÇÑ º¸¾È Á¶Ä¡¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© ¸®½ºÅ©¸¦ ÁÙ¿©¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, µ¿ÀÇ ÇÁ·Î¼¼½º ÀÚüµµ ȯÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¸¦ º¸È£ÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î¾ß ÇÕ´Ï´Ù. ȯÀÚ´Â ÀÚ½ÅÀÇ °³ÀÎ ÀÇ·á Á¤º¸°¡ À߸ø Ãë±ÞµÇÁö ¾ÊÀ» °ÍÀ̶ó´Â È®½ÅÀ» °¡Á®¾ß Çϴµ¥, À̰ÍÀÌ Á¦´ë·Î ÇØ°áµÇÁö ¾ÊÀ¸¸é µµÀÔ¿¡ Å« À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

Á¢±Ù¼º ¹× Æ÷¿ë¼º

EConsent´Â ¸¹Àº ÀåÁ¡À» °¡Áö°í ÀÖÁö¸¸, Á¢±Ù¼º°ú Æ÷°ý¼º¿¡ ´ëÇÑ ¿ì·Áµµ ÀÖ½À´Ï´Ù. ¸ðµç ȯÀÚ°¡ µðÁöÅÐ ±â±â³ª ÀÎÅͳݿ¡ ¶È°°ÀÌ Á¢±ÙÇÒ ¼ö ÀÖ´Â °ÍÀº ¾Æ´Ï±â ¶§¹®¿¡ ÀÇ·á µ¿ÀÇ °úÁ¤¿¡ °ÝÂ÷°¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â EConsent ¼Ö·ç¼ÇÀÌ Àå¾Ö°¡ Àְųª µðÁöÅÐ ¹®ÇØ·ÂÀÌ Á¦ÇÑÀûÀΠȯÀÚ µî ´Ù¾çÇÑ È¯ÀÚ°¡ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, ¼¼°è ȯ°æ¿¡¼­´Â ¾ð¾î À庮ÀÌ Å« ¹®Á¦°¡ µÉ ¼ö ÀÖÀ¸¸ç, EConsent ¼Ö·ç¼ÇÀº ´Ù¾çÇÑ È¯ÀÚ±ºÀ» ¼ö¿ëÇϱâ À§ÇØ ´Ù±¹¾î·Î Á¦°øµÇ¾î¾ß ÇÕ´Ï´Ù.

±âÁ¸ ½Ã½ºÅÛ°úÀÇ ÅëÇÕ

ÀÇ·á ±â°üÀº Á¾Á¾ ¸¹Àº ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ½Ã½ºÅÛ¿¡ ÀÇÁ¸Çϰí ÀÖÀ¸¸ç, EConsent ¼Ö·ç¼Ç°ú ÀÌ·¯ÇÑ ±âÁ¸ ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀº º¹ÀâÇÑ ÀÛ¾÷ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¿øÈ°ÇÑ ÅëÇÕÀº È¿À²ÀûÀÎ µ¥ÀÌÅÍ ±³È¯À» À§ÇØ ÇʼöÀûÀ̸ç, ÀÌÁß µ¥ÀÌÅÍ ÀÔ·ÂÀ» ÇÇÇÏ´Â °ÍÀº ȯÀÚ Ä¡·áÀÇ ¿À·ù¿Í Áö¿¬À¸·Î À̾îÁú ¼ö ÀÖÀ¸¹Ç·Î EConsent Á¦°ø¾÷ü´Â »óÈ£ ¿î¿ë °¡´ÉÇÑ ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϰí ÀÇ·á ±â°ü°ú ±ä¹ÐÈ÷ Çù·ÂÇÏ¿© Ç÷§ÆûÀÌ ´Ù¾çÇÑ EHR ½Ã½ºÅÛ°ú ¿øÈ°ÇÏ°Ô ÅëÇÕµÉ ¼ö ÀÖµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù. ÀÌ ´Ù¾çÇÑ EHR ½Ã½ºÅÛ°ú ¿øÈ°ÇÏ°Ô ÅëÇÕµÉ ¼ö ÀÖµµ·Ï ÀÇ·á ±â°ü°ú ±ä¹ÐÇÏ°Ô Çù·ÂÇØ¾ß ÇÕ´Ï´Ù.

ȯÀÚ ±³À° ¹× ¼Ò°³

EConsent ¼Ö·ç¼ÇÀ» äÅÃÇÏ·Á¸é ÀÇ·á ¼­ºñ½º Á¦°øÀÚ»Ó¸¸ ¾Æ´Ï¶ó ȯÀÚµµ »õ·Î¿î ÇÁ·Î¼¼½º¿¡ ÀûÀÀÇØ¾ß ÇÕ´Ï´Ù. ¸¹Àº ȯÀÚµéÀº Á¾ÀÌ µ¿ÀǼ­¿¡ ¼­¸íÇÏ´Â °Í¿¡ Àͼ÷ÇØÁ® ÀÖ¾î µðÁöÅзΠ´ëüÇÏ´Â ¹æ½Ä¿¡ ÁÖÀúÇϰųª °ÅºÎ°¨À» ´À³¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀúÇ×À» ±Øº¹Çϱâ À§Çؼ­´Â È¿°úÀûÀΠȯÀÚ ±³À°°ú Ä¿¹Â´ÏÄÉÀ̼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â Á÷¿ø ±³À°¿¡ ÅõÀÚÇϰí, ȯÀÚ¿¡°Ô EConsentÀÇ ÀÌÁ¡À» ¾Ë¸®°í, µ¥ÀÌÅÍ ¾ÈÀü°ú µðÁöÅÐ ÇÁ·Î¼¼½º°¡ È¿À²ÀûÀÌ°í ¹ýÀû ±¸¼Ó·ÂÀ» °®µµ·Ï º¸ÀåÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ

±â¼úÀÇ Áøº¸

ÀüÀÚ ¼­¸í ±â¼úÀº Á¾ÀÌ ¾ø´Â µ¿ÀÇ ÀýÂ÷ÀÇ ±æÀ» ¿­¾ú½À´Ï´Ù. ȯÀÚµéÀº µðÁöÅÐ ¼­¸íÀ» ÅëÇØ µ¿ÀǼ­¿¡ ¾ÈÀüÇÏ°Ô ¼­¸íÇÒ ¼ö ÀÖ°Ô µÇ¾î ¹°¸®Àû ¼­·ù°¡ ÇÊ¿ä ¾ø°Ô µÇ¾ú½À´Ï´Ù. ÀÌ´Â °ü¸® ºÎ´ãÀ» ÁÙ¿©ÁÙ »Ó¸¸ ¾Æ´Ï¶ó µ¿ÀǼ­¸¦ ¾ÈÀüÇÏ°Ô º¸°üÇÏ°í ½±°Ô °Ë»öÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ½º¸¶Æ®Æù°ú ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀÇ º¸±ÞÀ¸·Î ¿ø°ÝÁö¿¡¼­µµ µ¿ÀǼ­¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ȯÀÚ´Â ¸ð¹ÙÀÏ ±â±â¿¡¼­ µ¿ÀǼ­¸¦ È®ÀÎÇÏ°í ¼­¸íÇÒ ¼ö ÀÖ¾î Á¢±Ù¼º°ú ÆíÀǼºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǿ¡´Â µ¿¿µ»ó, ÀÎÅÍ·¢Æ¼ºê ÄÁÅÙÃ÷ µî ¸ÖƼ¹Ìµð¾î ¿ä¼Òµµ Æ÷Ç﵃ ¼ö ÀÖ¾î ȯÀÚÀÇ ÀÌÇØµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ µ¥ÀÌÅÍÀÇ º¸¾È°ú ÇÁ¶óÀ̹ö½Ã º¸ÀåÀº °¡Àå Áß¿äÇÕ´Ï´Ù. ºí·ÏüÀÎ ±â¼úÀº °­·ÂÇÑ µ¥ÀÌÅÍ º¸¾È ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ±ÇÇÑÀÌ ¾ø´Â ´ç»çÀÚ°¡ µ¿ÀÇ ¹®¼­¸¦ º¯Á¶ÇÏ´Â °ÍÀ» ¾î·Æ°Ô ¸¸µì´Ï´Ù. À̸¦ ÅëÇØ ȯÀÚÀÇ ½Å·Ú¿Í µ¿ÀÇ ÀýÂ÷ Áؼö¸¦ °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

AI¿Í NLP ¾Ë°í¸®ÁòÀº µ¿ÀǼ­ °ËÅä¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. º¹ÀâÇÑ ÀÇ·á ¿ë¾î¸¦ ½Äº°Çϰí, ÀáÀçÀû ÀÎ ¹®Á¦¸¦ Ç¥½ÃÇϰí, ȯÀÚ¿¡°Ô ÀÌÇØÇϱ⠽¬¿î ¾ð¾î·Î ¼³¸íÀ» Á¦°ø ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº µ¿ÀÇ °úÁ¤ÀÇ ¼Óµµ¸¦ ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ°¡ ³»¿ëÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ¸ç, EHR°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀº ȯÀÚ Á¤º¸¿Í º´·ÂÀ» ÀÚµ¿À¸·Î ÀÔ·ÂÇÔÀ¸·Î½á µ¿ÀÇ °úÁ¤À» °£¼ÒÈ­ÇÕ´Ï´Ù. À̸¦ ÅëÇØ ÀÇ·áÁøÀº ½Ç¼ö¸¦ ÁÙÀÌ°í ½Ã°£À» Àý¾àÇÒ ¼ö ÀÖ¾î ȯÀÚ Ä¡·á¿¡ ´õ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸¸¦ EConsent ÇÁ·Î¼¼½º¿¡ ÅëÇÕÇÏ´Â °ÍÀº ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ¸¹Àº ÀÌÁ¡À» °¡Á®´ÙÁÝ´Ï´Ù. ¸ÖƼ¹Ìµð¾î ¿ä¼Ò¿Í °£¼ÒÈ­µÈ ¾ð¾î´Â ȯÀÚ°¡ µ¿ÀǼ­¿¡ ±âÀçµÈ Á¤º¸¸¦ º¸´Ù ½±°Ô ÀÌÇØÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ¸ç, ȯÀÚ°¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. °í±Þ ¾Ïȣȭ¿Í ºí·ÏüÀÎ ±â¼úÀº µ¿ÀǼ­ÀÇ ±â¹Ð¼º°ú ¹«°á¼ºÀ» º¸ÀåÇÏ°í µ¥ÀÌÅÍ À¯ÃâÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ÀüÀÚÈ­µÈ ÇÁ·Î¼¼½º´Â µ¿ÀÇ¿Í °ü·ÃµÈ °ü¸® ¾÷¹«¸¦ ÁÙ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ȯÀÚ Ä¡·á¿¡ ´õ ¸¹Àº ½Ã°£À» ÇÒ¾ÖÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ȯÀÚ´Â Áý¿¡¼­ µ¿ÀǼ­¸¦ Á¦ÃâÇÒ ¼ö Àֱ⠶§¹®¿¡ °æ¹ÌÇÑ ½Ã¼úÀ̳ª Áø·á¸¦ À§ÇØ º´¿øÀ» ¹æ¹®ÇÏÁö ¾Ê¾Æµµ µË´Ï´Ù. µ¿ÀǼ­ÀÇ ÀüÀÚÀû ÀúÀå ¹× °Ë»öÀº ±â·Ï °ü¸® ¹× °¨»ç¸¦ °£¼ÒÈ­ÇÏ¿© ¼­·ù ÀÛ¾÷À» ÁÙÀÌ°í ±ÔÁ¤ Áؼö¸¦ Çâ»ó½Ãŵ´Ï´Ù.

ºÎ¹®º° ÀλçÀÌÆ®

Ç÷§Æûº° ÀλçÀÌÆ®

Ç÷§ÆûÀÇ ¹üÁÖ¿¡ µû¶ó, Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®Àº 2022³â ÇコÄÉ¾î ºÐ¾ßÀÇ EConsent ¼¼°è ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ ½ÃÀå ÁøÀÔÀÚ·Î ºÎ»óÇß½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀº Ź¿ùÇÑ È®À强À» Á¦°øÇϱ⠶§¹®¿¡ ÀÇ·á ±â¾÷Àº Çʿ信 µû¶ó EConsent ¼Ö·ç¼ÇÀ» ½±°Ô È®ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À¯¿¬¼ºÀº ȯÀÚ µ¥ÀÌÅÍÀÇ ¾ç°ú ÀÇ·á ½Ã½ºÅÛÀÇ º¹À⼺ÀÌ ¸Å¿ì ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀº ´ëºÎºÐ ±¸µ¶ ±â¹Ý ¸ðµ¨À» äÅÃÇϰí Àֱ⠶§¹®¿¡ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ÀÚüÀûÀ¸·Î ÀÎÇÁ¶ó¸¦ ±¸ÃàÇϰí À¯ÁöÇÏ´Â °Íº¸´Ù ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù. ÀÌ´Â Ãʱâ ÅõÀÚ ¹× Áö¼ÓÀûÀÎ À¯Áöº¸¼ö ºñ¿ëÀ» ÁÙ¿© ´õ ¸¹Àº ÀÇ·á ±â°üÀÌ EConsent ¼Ö·ç¼ÇÀ» ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº ¿ÂÇÁ·¹¹Ì½º¿¡ ºñÇØ µµÀÔÀÌ ´õ ºü¸¨´Ï´Ù. ÀÌ´Â ¸Å¿ì Áß¿äÇѵ¥, ÀÌ´Â ÀÇ·á ÇöÀå¿¡¼­ ¸Å¿ì Áß¿äÇѵ¥, EConsent ¼Ö·ç¼ÇÀ» ½Å¼ÓÇÏ°Ô µµÀÔÇÒ ¼ö ÀÖ´Ù´Â °ÍÀº ȯÀÚ °æÇèÀ» °³¼±Çϰí ÀÇ·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Ù´Â °ÍÀ» ÀǹÌÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ÀÎÅͳÝÀÌ ¿¬°áµÈ °÷À̶ó¸é ¾îµð¼­µç ¾ÈÀüÇÏ°Ô EConsent µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù¼ºÀº ÀÇ·áÁø °£ÀÇ Çù¾÷À» ÃËÁøÇϰí Ãֽе¿ÀÇ Á¤º¸¸¦ Áï½Ã ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¸¹Àº Ŭ¶ó¿ìµå ¼­ºñ½º Á¦°ø¾÷üµéÀÌ º¸¾È Á¶Ä¡¿Í ÄÄÇöóÀ̾𽺠ÀÎÁõ¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¿ÂÇÁ·¹¹Ì½º ¼Ö·ç¼ÇÀ¸·Î´Â ±¸ÇöÇÏ±â ¾î·Æ°í ºñ¿ëÀÌ ¸¹ÀÌ µå´Â µ¥ÀÌÅÍ º¸¾È°ú ±ÔÁ¦ Áؼö¸¦ ÀÇ·á ±â°ü¿¡ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

µî·Ï À¯Çüº° ÀλçÀÌÆ®

¿¹Ãø ±â°£ µ¿¾È ÇöÀå µî·Ï ºÎ¹®Àº ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, EConsentÀÇ ÇöÀå µî·ÏÀº Á¾Á¾ ÀÇ·á ±ÔÁ¦ ¿ä°Ç¿¡ ºÎÇÕÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¸¹Àº Áö¿ª¿¡¼­ »çÀü µ¿ÀÇ ÇÁ·Î¼¼½º¸¦ °ü¸®Çϴ ƯÁ¤ ±ÔÁ¤ÀÌ ÀÖÀ¸¸ç, ÇöÀå µî·ÏÀº ÇÊ¿äÇÑ ¸ðµç ´Ü°è¿Í ¹®¼­È­°¡ ÀÌ·¯ÇÑ ±ÔÁ¤À» ÁؼöÇÏ¿© ¿Ï·áµÇµµ·Ï º¸ÀåÇÕ´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀº ¹ýÀû À§ÇèÀ» ÁÙÀ̱â À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ¼±È£ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹æ¹® µî·ÏÀº ÀÇ·á Àü¹®°¡°¡ ȯÀÚ¿Í Á÷Á¢ ¼ÒÅëÇÏ°í µ¿ÀÇ ÀýÂ÷¸¦ öÀúÈ÷ ¼³¸íÇÏ¸ç ¸ðµç Áú¹®¿¡ ½Ç½Ã°£À¸·Î ´äº¯ÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. À̸¦ ÅëÇØ ȯÀÚ´Â Ä¡·á, ½Ã¼ú ¹× °ü·Ã À§Çè¿¡ ´ëÇØ ´õ Àß ÀÌÇØÇϰí, »çÀü µ¿ÀÇ(informed consent) °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ´Â ÀÚ½ÅÀÌ ¾Ë°í ½Å·ÚÇÏ´Â ÀÇ·á Àü¹®°¡°¡ Á÷Á¢ µ¿ÀÇ ÀýÂ÷¸¦ ÁøÇàÇÏ¸é µ¿ÀÇ ÀýÂ÷¿¡ ´ëÇÑ ½Å·Ú°¡ ³ô¾ÆÁú ¼ö ÀÖ½À´Ï´Ù. À̴ ȯÀÚ°¡ ºÒ¾È°¨À» ´À³¢°Å³ª Ãß°¡ÀûÀÎ ¾È½É°¨À» ÇÊ¿ä·Î ÇÏ´Â º¹ÀâÇÑ ÀÇ·á ÇàÀ§³ª °íÀ§Çè ÀÇ·á ÇàÀ§¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. °æ¿ì¿¡ µû¶ó¼­´Â ¹®¼­ÀÇ ¿ÏÀü¼º Ãø¸é¿¡¼­ ¹æ¹® µî·ÏÀÌ ´õ ¾ÈÀüÇÑ °ÍÀ¸·Î ÀÎ½ÄµÉ ¼öµµ ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â µ¿ÀǼ­°¡ Á¤È®ÇÏ°Ô ÀÛ¼ºµÇ°í ÇÊ¿äÇÑ ¼­¸íÀ» ¸ðµÎ ¹Þ¾Ò´ÂÁö È®ÀÎÇÒ ¼ö ÀÖ¾î ¿À·ù³ª ´©¶ôÀÌ ¹ß»ýÇÒ °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®

ºÏ¹Ì Áö¿ªÀÌ 2022³â ¼¼°è ÇコÄÉ¾î ºÐ¾ß ÀüÀÚµ¿ÀÇ(EConsent) ½ÃÀå¿¡¼­ ±Ý¾× ±âÁØÀ¸·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϸç Áö¹èÀûÀÎ ½ÃÀå ÁøÀÔÀÚ·Î ºÎ»óÇß½À´Ï´Ù. ºÏ¹Ì, ƯÈ÷ ¹Ì±¹°ú ij³ª´Ù´Â ±â¼ú ¹ßÀü°ú Çõ½Å¿¡¼­ ¼¼°è¸¦ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ÀÇ·á ºÐ¾ßµµ Æ÷ÇԵǸç, ÀüÀڰǰ­±â·Ï(EHR), ¿ø°Ý ÀÇ·á ¹× ±âŸ µðÁöÅÐ ÀÇ·á ¼Ö·ç¼ÇÀÌ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ÀÎÇÁ¶ó´Â EConsent ¼Ö·ç¼Ç µµÀÔ¿¡ ÀûÇÕÇÑ È¯°æÀ» Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡´Â ¹Ì±¹ÀÇ ÀǷẸÇè »óÈ£¿î¿ë¼º ¹× Ã¥ÀÓ¿¡ °üÇÑ ¹ý·ü(HIPAA)°ú ij³ª´ÙÀÇ À¯»çÇÑ ±ÔÁ¦ µî È®¸³µÈ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦´Â ȯÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¿Í µ¥ÀÌÅÍ º¸¾ÈÀÇ Á߿伺À» °­Á¶Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¾ÈÀüÇÏ°í ±â¹ÐÀÌ À¯ÁöµÇ´Â µ¿ÀÇ ÇÁ·Î¼¼½º¸¦ º¸ÀåÇÏ´Â EConsent ¼Ö·ç¼ÇÀÇ ¸ñÇ¥¿Í ÀÏÄ¡ÇÕ´Ï´Ù. ºÏ¹Ì¿¡´Â ¼¼°è¿¡¼­ °¡Àå Å©°í º¹ÀâÇÑ ÀÇ·á ½Ã½ºÅÛÀÌ ÀÖ½À´Ï´Ù. ¼ö¹é¸¸ ¸íÀÇ È¯ÀÚ µ¿ÀǼ­¿Í ¹®¼­¸¦ °ü¸®ÇÏ´Â °ÍÀº ¾î·Á¿î ÀÏÀÌÁö¸¸, EConsent ¼Ö·ç¼ÇÀº ÀÌ °úÁ¤À» ÇÕ¸®ÀûÀ̰í È¿À²ÀûÀ¸·Î ó¸®ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ÇコÄɾî¿ë EConsent ¼¼°è ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Ç÷§Æûº°(Ŭ¶ó¿ìµå ±â¹Ý, À¥ ±â¹Ý)
    • µî·Ï À¯Çüº°(¿Â»çÀÌÆ®, ¿ø°Ý)
    • Æû À¯Çüº°(ÀÏ¹Ý µ¿ÀÇ, ƯÁ¤ °ÅºÎ¸¦ ¼ö¹ÝÇÏ´Â ÀÏ¹Ý µ¿ÀÇ, ƯÁ¤ µ¿ÀǸ¦ ¼ö¹ÝÇÏ´Â ÀÏ¹Ý °ÅºÎ, ÀÏ¹Ý °ÅºÎ)
    • Áö¿ªº°
    • ±â¾÷º°(2022³â)
  • ½ÃÀå ¸Ê

Á¦6Àå ºÏ¹ÌÀÇ ÇコÄɾî¿ë EConsent ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Ç÷§Æûº°
    • µî·Ï À¯Çüº°
    • Æû À¯Çüº°
    • ±¹°¡º°
  • ºÏ¹Ì : ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦7Àå À¯·´ÀÇ ÇコÄɾî¿ë EConsent ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Ç÷§Æûº°
    • µî·Ï À¯Çüº°
    • Æû À¯Çüº°
  • À¯·´ : ±¹°¡º° ºÐ¼®
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄɾî¿ë EConsent ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Ç÷§Æûº°
    • µî·Ï À¯Çüº°
    • Æû À¯Çüº°
  • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ

Á¦9Àå ³²¹ÌÀÇ ÇコÄɾî¿ë EConsent ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Ç÷§Æûº°
    • µî·Ï À¯Çüº°
    • Æû À¯Çüº°
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄɾî¿ë EConsent ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Ç÷§Æûº°
    • µî·Ï À¯Çüº°
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÀμöÇÕº´
  • Á¦Ç° °³¹ß

Á¦13Àå ÇコÄɾî¿ë EConsent ¼¼°è ½ÃÀå SWOT ºÐ¼®

Á¦14Àå °æÀï »óȲ

  • Veeva Systems Inc.
  • Wellbeing Software, a Citadel Group
  • Florence Healthcare Inc.
  • Concentric Health Ltd
  • 5thPort, LLC
  • Cloudbyz Inc.
  • Calysta EMR
  • Interlace Health, LLC
  • Thieme Compliance GmbH

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå Á¶»ç ȸ»ç ¹× ¸éÃ¥»çÇ×

ksm 23.11.14

Global EConsent In Healthcare Market has valued at USD 301.03 million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 11.73% through 2028. In recent years, the healthcare industry has witnessed a monumental transformation in the way patients engage with their healthcare providers. One of the most significant developments is the widespread adoption of electronic informed consent (eConsent). This technological advancement has not only streamlined administrative processes but has also empowered patients to become more actively involved in their healthcare decisions.

Traditionally, obtaining informed consent from patients for medical procedures or clinical trials involved extensive paperwork and sometimes confusing legal jargon. Patients often felt overwhelmed, making it challenging to truly understand the implications of their decisions. However, eConsent has changed this landscape by offering a more patient-centric approach. eConsent involves the use of electronic platforms, such as tablets, smartphones, or web applications, to present consent information to patients in a clear and interactive manner. Patients can review the details, ask questions, and electronically sign consent forms, all while having access to educational materials and multimedia resources to aid their understanding.

The shift towards patient-centered healthcare is a key driver. Patients are increasingly taking an active role in their healthcare decisions and demanding transparency and convenience. Stringent regulatory requirements in healthcare, such as the GDPR in Europe and HIPAA in the United States, are pushing healthcare providers to adopt secure and compliant eConsent solutions. The proliferation of smartphones and tablets, along with improved internet connectivity, has made it easier for healthcare organizations to implement eConsent solutions. eConsent reduces administrative burden, decreases paperwork, and streamlines the consent process, ultimately saving time and costs for healthcare providers. The COVID-19 pandemic accelerated the adoption of remote and decentralized clinical trials, where eConsent plays a crucial role in obtaining informed consent from participants. The global eConsent in healthcare market is revolutionizing the way patients participate in their healthcare decisions. By fostering a more transparent, efficient, and patient-centric approach to informed consent, eConsent not only benefits patients but also healthcare providers and researchers. As technology continues to advance and the healthcare industry adapts to evolving patient needs, eConsent is poised to play an increasingly central role in modern healthcare practices.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 301.03 Million
Market Size 2028USD 583.22 Million
CAGR 2023-202811.73%
Fastest Growing SegmentGeneral Consent
Largest MarketNorth America

Key Market Drivers

Enhanced Patient Engagement is Driving the Global EConsent In Healthcare Market

In recent years, healthcare has been undergoing a remarkable transformation fueled by technological advancements and changing patient expectations. One of the significant trends that have emerged is the adoption of electronic consent (eConsent) solutions, revolutionizing the way patients interact with their healthcare providers. Enhanced patient engagement plays a pivotal role in driving the global eConsent in healthcare market, reshaping the informed consent process and improving patient outcomes. Enhanced patient engagement, fueled by the digital transformation of healthcare, is changing the landscape. EConsent platforms leverage multimedia elements like videos, animations, and simplified language to present medical information to patients. This makes it easier for patients to understand their treatment options, risks, and benefits, thereby empowering them to make informed decisions. Patients can communicate with their healthcare providers through eConsent platforms, asking questions and seeking clarification at their convenience. This fosters a sense of involvement in their care, reducing anxiety and enhancing trust. EConsent solutions often integrate with electronic health records (EHRs), enabling patients to access their medical history, test results, and treatment plans. This transparency allows patients to actively participate in discussions about their care. Patients can provide consent remotely, which is especially crucial in the era of telemedicine. This flexibility ensures that even patients who cannot physically visit a healthcare facility can actively engage in their care decisions.

Increasing Streamlined Workflows is Driving the Global Men's Health Supplements Market

The global e-consent market is experiencing rapid growth, driven primarily by the need for streamlined workflows in healthcare settings. Informed consent is a fundamental aspect of medical practice, ensuring that patients understand the risks and benefits of a medical procedure or treatment before providing their approval. Traditionally, this process involved paper forms and lengthy discussions between patients and healthcare providers. However, in recent years, healthcare has transitioned towards electronic consent solutions, a shift that has been catalyzed by several factors. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have recognized the benefits of e-consent. They have developed guidelines and regulations that encourage the adoption of electronic consent processes, emphasizing the importance of patient comprehension and compliance. This regulatory push has motivated healthcare organizations to adopt e-consent solutions that meet these standards. Patient-centric care is a driving force behind healthcare innovations, and e-consent aligns perfectly with this principle. Patients appreciate the convenience of digitally signing consent forms from the comfort of their own devices, avoiding the hassle of paper forms and reducing wait times. This improved patient experience leads to higher patient satisfaction and engagement.

As the global healthcare industry continues to embrace digitalization, the eConsent market is poised for substantial growth. The COVID-19 pandemic accelerated the adoption of digital healthcare solutions, including eConsent, and this trend is expected to persist. Furthermore, ongoing developments in technology, such as artificial intelligence and blockchain, are likely to enhance eConsent solutions, making them even more efficient and secure. Integration with electronic health records (EHRs) and interoperability with other healthcare systems will further streamline workflows, improving the overall patient experience.

Streamlined workflows powered by eConsent technology are revolutionizing the global healthcare industry by simplifying the informed consent process. These solutions are promoting patient engagement, reducing administrative burdens, and enhancing compliance, all while ensuring data security and remote accessibility. As the healthcare sector continues its digital transformation journey, the eConsent market is set to grow, further improving the quality of patient care and the efficiency of healthcare delivery worldwide. Healthcare providers and organizations that embrace eConsent technology will be better positioned to meet the evolving needs of both patients and the industry.

Key Market Challenges

Regulatory Challenges

One of the foremost challenges in the global EConsent in healthcare market is maintaining compliance with ever-evolving regulatory requirements. Healthcare is highly regulated, and EConsent solutions must adhere to a multitude of regional and national laws governing patient privacy, data security, and consent documentation. Ensuring that EConsent platforms meet these varying standards across different countries and regions can be complex and costly. The introduction of new regulations, like the European Union's General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA) in the United States, has added an extra layer of complexity. EConsent providers must continuously update their systems to stay compliant, which can be challenging and resource-intensive.

Data Security and Privacy

EConsent platforms deal with sensitive patient information, making data security and privacy a top concern. Ensuring that patient data is protected from breaches or unauthorized access is crucial. As cyber threats continue to evolve, EConsent providers must invest heavily in robust security measures and regularly update them to mitigate risks. Additionally, the consent process itself must be designed to protect patient privacy. Patients must have confidence that their personal health information will not be mishandled, which can be a significant barrier to adoption if not properly addressed.

Accessibility and Inclusivity

While EConsent offers numerous benefits, it also raises concerns about accessibility and inclusivity. Not all patients have equal access to digital devices or the internet, which can create disparities in healthcare consent processes. Providers need to ensure that EConsent solutions are accessible to a broad range of patients, including those with disabilities and limited digital literacy. Moreover, language barriers can be a significant challenge in a global context. EConsent solutions must be available in multiple languages to accommodate diverse patient populations.

Integration with Existing Systems

Healthcare facilities often rely on a multitude of electronic health record (EHR) systems, and integrating EConsent solutions with these existing systems can be a complex task. Seamless integration is essential for efficient data exchange and to avoid double data entry, which can lead to errors and delays in patient care. EConsent providers must invest in interoperable solutions and work closely with healthcare institutions to ensure that their platforms can integrate smoothly with various EHR systems.

Patient Education and Adoption

Adopting EConsent solutions requires not only healthcare providers but also patients to adapt to new processes. Many patients are accustomed to signing paper consent forms and may be hesitant or resistant to digital alternatives. Overcoming this resistance requires effective patient education and communication.

Healthcare providers must invest in training for their staff and educate patients on the benefits of EConsent, assuring them that their data will be secure and that the digital process is both efficient and legally binding.

Key Market Trends

Technological Advancements

Electronic signature technology has paved the way for paperless consent processes. Patients can now sign consent forms securely using digital signatures, eliminating the need for physical paperwork. This not only reduces administrative burdens but also ensures that consent documents are securely stored and easily retrievable. The proliferation of smartphones and mobile applications has made it possible to obtain consent remotely. Patients can review and sign consent forms on their mobile devices, increasing accessibility and convenience. Mobile applications can also include multimedia elements, such as videos and interactive content, to enhance patient comprehension. Ensuring the security and privacy of patient data is paramount. Blockchain technology offers robust data security solutions, making it difficult for unauthorized parties to tamper with consent documents. This enhances patient trust and compliance with the consent process.

AI and NLP algorithms can assist in the review of consent forms. They can identify complex medical terminology, flag potential issues, and offer explanations to patients in plain language. This technology not only speeds up the consent process but also ensures patients have a clearer understanding of the content. Seamless integration with EHRs streamlines the consent process by automatically populating patient information and medical history. This reduces errors and saves time for healthcare providers, allowing them to focus more on patient care.

The integration of these technological advancements into eConsent processes brings about numerous benefits for both patients and healthcare providers. Multimedia elements and simplified language help patients better understand the information presented in consent forms, enabling them to make more informed decisions. Advanced encryption and blockchain technology ensure the confidentiality and integrity of consent documents, reducing the risk of data breaches. Electronic processes reduce administrative tasks associated with consent, allowing healthcare providers to allocate more time to patient care. Patients can provide consent from the comfort of their homes, eliminating the need for in-person visits for minor procedures or consultations. Electronic storage and retrieval of consent documents simplify record-keeping and audits, reducing paperwork and improving compliance.

Segmental Insights

Platform Insights

Based on the category of Platform, the Cloud-based segment emerged as the dominant player in the global market for EConsent In Healthcare in 2022. Cloud-based platforms offer unparalleled scalability, allowing healthcare organizations to easily expand their eConsent solutions as needed. This flexibility is crucial in the healthcare sector, where the volume of patient data and the complexity of healthcare systems can vary widely. Cloud-based platforms often follow a subscription-based model, which can be more cost-effective for healthcare providers than building and maintaining their own infrastructure. This reduces the upfront capital expenditure and ongoing maintenance costs, making eConsent solutions more accessible to a wider range of healthcare organizations. Cloud-based solutions can be implemented quickly compared to on-premises alternatives. This is crucial in healthcare, where time-sensitive decisions often need to be made. The ability to deploy eConsent solutions rapidly can lead to improved patient experiences and better healthcare outcomes. Cloud-based platforms enable healthcare providers to access eConsent data securely from anywhere with an internet connection. This accessibility fosters collaboration among healthcare professionals and ensures that the most up-to-date consent information is readily available. Many cloud service providers invest heavily in security measures and compliance certifications. This can provide healthcare organizations with a level of data security and regulatory compliance that may be difficult and costly to achieve with on-premises solutions.

Enrollment Type Insights

The onsite segment is projected to experience rapid growth during the forecast period. Onsite enrollment for eConsent often aligns better with healthcare regulatory requirements. Many regions have specific regulations governing informed consent processes, and onsite enrollment can ensure that all necessary steps and documentation are completed in compliance with these regulations. This approach may be preferred by healthcare providers to mitigate legal risks. In onsite enrollment, healthcare professionals have the opportunity to directly engage with patients, explain the consent process thoroughly, and answer any questions in real-time. This can enhance patient understanding of the treatment or procedure and the associated risks, leading to more informed consent decisions. Patients may have more confidence in the consent process when conducted in person by healthcare professionals they know and trust. This can be especially important for complex or high-risk medical procedures where patients may have concerns or require additional reassurance. In some cases, onsite enrollment may be perceived as more secure in terms of document integrity. Healthcare providers can ensure that the consent documents are completed accurately, all necessary signatures are obtained, and there is less chance of errors or omissions.

Regional Insights

North America emerged as the dominant player in the global EConsent In Healthcare market in 2022, holding the largest market share in terms of value North America, particularly the United States and Canada, has been a global leader in technological advancements and innovation. This includes the healthcare sector, where electronic health records (EHRs), telemedicine, and other digital healthcare solutions have been widely adopted. This technological infrastructure creates a conducive environment for the implementation of eConsent solutions. North America has well-established regulatory frameworks, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States and similar regulations in Canada. These regulations emphasize the importance of patient privacy and data security, which aligns with the goals of eConsent solutions to ensure secure and confidential consent processes. North America boasts some of the world's largest and most complex healthcare systems. Managing consent forms and documentation for millions of patients can be a daunting task, and eConsent solutions offer a streamlined and efficient way to handle this process.

Key Market Players

  • Veeva Systems Inc.
  • Wellbeing Software, a Citadel Group
  • Florence Healthcare Inc.
  • Concentric Health Ltd
  • 5thPort, LLC
  • Cloudbyz Inc.
  • Calysta EMR
  • Interlace Health, LLC
  • Thieme Compliance GmbH

Report Scope:

In this report, the Global eConsent In Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamins Supplements Market, By Platform:

  • Cloud-based
  • Web-based

Vitamins Supplements Market, By Enrollment Type:

  • On-site
  • Remote

Vitamins Supplements Market, By Form Type:

  • General Consent
  • General Consent with Specific Denial(s)
  • General Denial with Specific Consent(s)
  • General Denial

Vitamins Supplements Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global EConsent In Healthcare Market.

Available Customizations:

  • Global eConsent In Healthcare market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global EConsent In Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Platform (Cloud-based, Web-based)
    • 5.2.2. By Enrollment Type (On-site, Remote)
    • 5.2.3. By Form Type ( General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), General Denial)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America EConsent In Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Platform
    • 6.2.2. By Enrollment Type
    • 6.2.3. By Form Type
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States EConsent In Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Platform
        • 6.3.1.2.2. By Enrollment Type
        • 6.3.1.2.3. By Form Type
    • 6.3.2. Canada EConsent In Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Platform
        • 6.3.2.2.2. By Enrollment Type
        • 6.3.2.2.3. By Form Type
    • 6.3.3. Mexico EConsent In Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Platform
        • 6.3.3.2.2. By Enrollment Type
        • 6.3.3.2.3. By Form Type

7. Europe EConsent In Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Platform
    • 7.2.2. By Enrollment Type
    • 7.2.3. By Form Type
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany EConsent In Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Platform
        • 7.3.1.2.2. By Enrollment Type
    • 7.3.2. United Kingdom EConsent In Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Platform
        • 7.3.2.2.2. By Enrollment Type
        • 7.3.2.2.3. By Form Type
    • 7.3.3. Italy EConsent In Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Platform
        • 7.3.3.2.2. By Enrollment Type
        • 7.3.3.2.3. By Form Type
    • 7.3.4. France EConsent In Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Platform
        • 7.3.4.2.2. By Enrollment Type
        • 7.3.4.2.3. By Form Type
    • 7.3.5. Spain EConsent In Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Platform
        • 7.3.5.2.2. By Enrollment Type
        • 7.3.5.2.3. By Form Type

8. Asia-Pacific EConsent In Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Platform
    • 8.2.2. By Enrollment Type
    • 8.2.3. By Form Type
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China EConsent In Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Platform
        • 8.3.1.2.2. By Enrollment Type
        • 8.3.1.2.3. By Form Type
    • 8.3.2. India EConsent In Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Platform
        • 8.3.2.2.2. By Enrollment Type
        • 8.3.2.2.3. By Form Type
    • 8.3.3. Japan EConsent In Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Platform
        • 8.3.3.2.2. By Enrollment Type
        • 8.3.3.2.3. By Form Type
    • 8.3.4. South Korea EConsent In Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Platform
        • 8.3.4.2.2. By Enrollment Type
        • 8.3.4.2.3. By Form Type
    • 8.3.5. Australia EConsent In Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Platform
        • 8.3.5.2.2. By Enrollment Type
        • 8.3.5.2.3. By Form Type
        • 8.3.5.2.4.

9. South America EConsent In Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Platform
    • 9.2.2. By Enrollment Type
    • 9.2.3. By Form Type
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil EConsent In Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Platform
        • 9.3.1.2.2. By Enrollment Type
        • 9.3.1.2.3. By Form Type
    • 9.3.2. Argentina EConsent In Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Platform
        • 9.3.2.2.2. By Enrollment Type
        • 9.3.2.2.3. By Form Type
    • 9.3.3. Colombia EConsent In Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Platform
        • 9.3.3.2.2. By Enrollment Type
        • 9.3.3.2.3. By Form Type

10. Middle East and Africa EConsent In Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Platform
    • 10.2.2. By Enrollment Type
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa EConsent In Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Platform
        • 10.3.1.2.2. By Enrollment Type
        • 10.3.1.2.3. By Form Type
    • 10.3.2. Saudi Arabia EConsent In Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Platform
        • 10.3.2.2.2. By Enrollment Type
        • 10.3.2.2.3. By Form Type
    • 10.3.3. UAE EConsent In Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Platform
        • 10.3.3.2.2. By Enrollment Type
        • 10.3.3.2.3. By Form Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition
  • 12.2. Product Development
  • 12.3. Recent Developments

13. Global EConsent In Healthcare Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Age Group Offerings
  • 14.3. Recent Developments
  • 14.4. Key Personnel
  • 14.5. SWOT Analysis
    • 14.5.1. Veeva Systems Inc.
    • 14.5.2. Wellbeing Software, a Citadel Group
    • 14.5.3. Florence Healthcare Inc.
    • 14.5.4. Concentric Health Ltd
    • 14.5.5. 5thPort, LLC
    • 14.5.6. Cloudbyz Inc.
    • 14.5.7. Calysta EMR
    • 14.5.8. Interlace Health, LLC
    • 14.5.9. Thieme Compliance GmbH

15. Strategic Recommendations

16. About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦